Jack Hirsh

55.1k total citations · 21 hit papers
350 papers, 38.4k citations indexed

About

Jack Hirsh is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Jack Hirsh has authored 350 papers receiving a total of 38.4k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Internal Medicine, 224 papers in Cardiology and Cardiovascular Medicine and 103 papers in Surgery. Recurrent topics in Jack Hirsh's work include Venous Thromboembolism Diagnosis and Management (228 papers), Atrial Fibrillation Management and Outcomes (141 papers) and Antiplatelet Therapy and Cardiovascular Diseases (71 papers). Jack Hirsh is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (228 papers), Atrial Fibrillation Management and Outcomes (141 papers) and Antiplatelet Therapy and Cardiovascular Diseases (71 papers). Jack Hirsh collaborates with scholars based in Canada, United States and Australia. Jack Hirsh's co-authors include Michael Gent, Jeffrey S. Ginsberg, Jeffrey I. Weitz, James E. Dalen, Jack Ansell, Robert Raschke, John W. Eikelboom, Alan K. Jacobson, Clive Kearon and Russell D. Hull and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jack Hirsh

346 papers receiving 35.8k citations

Hit Papers

Heparin-Induced Thrombocytopenia in Patients Trea... 1972 2026 1990 2008 1995 2008 2001 2004 1996 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
    1995 1.7k citations Jack Hirsh, Michael Gent et al. New England Journal of Medicine profile →
  2. Pharmacology and Management of the Vitamin K Antagonists
    2008 1.6k citations Jack Ansell, Jack Hirsh et al. CHEST Journal profile →
  3. Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
    2001 1.2k citations Jack Hirsh, Sonia S. Anand et al. CHEST Journal profile →
  4. The Pharmacology and Management of the Vitamin K Antagonists
    2004 1.1k citations Jack Ansell, Jack Hirsh et al. CHEST Journal profile →
  5. A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis
    1996 872 citations Michael Gent, Jack Hirsh et al. New England Journal of Medicine profile →
  6. Heparin and Low-Molecular-Weight Heparin
    1998 817 citations Jack Hirsh, James E. Dalen et al. CHEST Journal profile →
  7. Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events
    2002 783 citations John W. Eikelboom, Jack Hirsh et al. profile →
  8. Platelet-Active Drugs
    2001 717 citations Carlo Patrono, Barry S. Coller et al. CHEST Journal profile →
  9. Heparin and Low-Molecular-Weight Heparin
    2004 702 citations Jack Hirsh et al. CHEST Journal profile →
  10. Heparin
    1991 646 citations John A. Oates, Alastair J.J. Wood et al. New England Journal of Medicine profile →
  11. American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
    2003 645 citations Jack Hirsh, Valentı́n Fuster et al. profile →
  12. A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
    2003 591 citations Mark Crowther, Jack Hirsh et al. New England Journal of Medicine profile →
  13. Management of Anticoagulation before and after Elective Surgery
    1997 565 citations Jack Hirsh et al. New England Journal of Medicine profile →
  14. Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein Thrombosis
    1986 560 citations Russell D. Hull, Jack Hirsh et al. New England Journal of Medicine profile →
  15. Antiplatelet Drugs
    2008 557 citations Carlo Patrono, Jack Hirsh et al. CHEST Journal profile →
  16. Parenteral Anticoagulants
    2008 518 citations Jack Hirsh, Michael K. Gould et al. CHEST Journal profile →
  17. Accuracy of clinical assessment of deep-vein thrombosis
    1995 514 citations Jack Hirsh, Jeffrey I. Weitz et al. profile →
  18. A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin Time
    1972 512 citations Jack Hirsh et al. New England Journal of Medicine profile →
  19. Warfarin Sodium versus Low-Dose Heparin in the Long-Term Treatment of Venous Thrombosis
    1979 457 citations Russell D. Hull, Edward Genton et al. New England Journal of Medicine profile →
  20. Heparin: Mechanism of Action, Pharmacokinetics, Dosing Considerations, Monitoring, Efficacy, and Safety
    1992 435 citations Jack Hirsh, James E. Dalen et al. CHEST Journal profile →
  21. Adjusted Subcutaneous Heparin versus Warfarin Sodium in the Long-Term Treatment of Venous Thrombosis
    1982 340 citations Russell D. Hull, Jack Hirsh et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Hirsh Canada 96 22.7k 22.3k 13.3k 8.2k 2.8k 350 38.4k
Jeffrey I. Weitz Canada 98 23.9k 1.1× 21.1k 0.9× 9.0k 0.7× 9.2k 1.1× 3.6k 1.3× 528 41.9k
Michael Gent Canada 90 20.2k 0.9× 16.1k 0.7× 9.1k 0.7× 5.1k 0.6× 5.7k 2.1× 230 34.9k
Mark Crowther Canada 93 19.7k 0.9× 21.4k 1.0× 10.3k 0.8× 9.2k 1.1× 4.0k 1.4× 584 40.0k
Harry R. Büller Netherlands 92 18.6k 0.8× 24.6k 1.1× 8.6k 0.6× 8.2k 1.0× 3.5k 1.3× 450 35.7k
John W. Eikelboom Canada 94 35.1k 1.5× 18.4k 0.8× 9.4k 0.7× 4.0k 0.5× 5.6k 2.0× 670 47.6k
Sam Schulman Canada 69 21.5k 0.9× 21.5k 1.0× 7.1k 0.5× 7.7k 0.9× 3.6k 1.3× 501 34.5k
John A. Heit United States 68 15.2k 0.7× 23.7k 1.1× 9.3k 0.7× 6.5k 0.8× 2.5k 0.9× 220 30.9k
Clive Kearon Canada 66 20.1k 0.9× 26.6k 1.2× 9.7k 0.7× 5.9k 0.7× 3.5k 1.3× 230 33.5k
Samuel Z. Goldhaber United States 100 27.6k 1.2× 35.0k 1.6× 10.6k 0.8× 5.4k 0.7× 6.6k 2.4× 614 47.4k
Mark N. Levine Canada 84 8.9k 0.4× 12.3k 0.6× 6.7k 0.5× 3.8k 0.5× 1.6k 0.6× 320 31.4k

Countries citing papers authored by Jack Hirsh

Since Specialization
Citations

This map shows the geographic impact of Jack Hirsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Hirsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Hirsh more than expected).

Fields of papers citing papers by Jack Hirsh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Hirsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Hirsh. The network helps show where Jack Hirsh may publish in the future.

Co-authorship network of co-authors of Jack Hirsh

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Hirsh. A scholar is included among the top collaborators of Jack Hirsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Hirsh. Jack Hirsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Noel, et al.. (2025). Anticoagulants: From chance discovery to structure-based design. Pharmacological Reviews. 77(2). 100037–100037. 1 indexed citations
2.
Bhagirath, Vinai, John W. Eikelboom, Ciro Martins Gomes, et al.. (2024). Usual On-therapy Ranges of Drug Concentrations in Patients with Atrial Fibrillation Treated with Direct Oral Anticoagulants: A Systematic Review and Meta-analysis. Thrombosis and Haemostasis. 125(6). 563–573. 1 indexed citations
3.
Hirsh, Jack, Vinai Bhagirath, Jeffrey S. Ginsberg, et al.. (2018). Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada. Journal of Thrombosis and Thrombolysis. 46(3). 310–315. 3 indexed citations
4.
Eikelboom, John W., Jack Hirsh, Frederick A. Spencer, Trevor Baglin, & Jeffrey I. Weitz. (2012). Antiplatelet Drugs. CHEST Journal. 141(2). e89S–e119S. 252 indexed citations
5.
Guyatt, Gordon, John W. Eikelboom, Michael K. Gould, et al.. (2012). Approach to Outcome Measurement in the Prevention of Thrombosis in Surgical and Medical Patients. CHEST Journal. 141(2). e185S–e194S. 144 indexed citations
6.
Paré, Guillaume, Shamir R. Mehta, Salim Yusuf, et al.. (2010). Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment. New England Journal of Medicine. 363(18). 1704–1714. 378 indexed citations
7.
Bates, Shannon M., Ian A. Greer, Jack Hirsh, & Jeffrey S. Ginsberg. (2004). Use of Antithrombotic Agents During Pregnancy. CHEST Journal. 126(3). 627S–644S. 341 indexed citations
8.
Hirsh, Jack, Valentı́n Fuster, Jack Ansell, & Jonathan L. Halperin. (2003). American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.. Journal of the American College of Cardiology. 41(9). 1633–1652. 229 indexed citations
9.
Patrono, Carlo, Barry S. Coller, James E. Dalen, et al.. (1998). The Relationships Among Dose, Effectiveness, and Side Effects. CHEST Journal. 114(5). 17 indexed citations
10.
Hirsh, Jack & William J. Williams. (1995). Deep Vein Thrombosis: Recovery or Recurrence?. Hospital Practice. 30(3). 71–79. 2 indexed citations
11.
Hirsh, Jack, et al.. (1994). Low molecular weight heparins. Current Opinion in Cardiology. 9(5). 612–618. 21 indexed citations
12.
Oates, John A., Alastair J.J. Wood, & Jack Hirsh. (1991). Heparin. New England Journal of Medicine. 324(22). 1565–1574. 646 indexed citations breakdown →
13.
Ofosu, Frederick A., I. Danishefsky, & Jack Hirsh. (1989). Preface. Annals of the New York Academy of Sciences. 556(1). 7 indexed citations
14.
Hirsh, Jack, et al.. (1989). Aspirin and Other Platelet Active Drugs. CHEST Journal. 95(2). 12S–18S. 5 indexed citations
15.
Hirsh, Jack & Russell D. Hull. (1987). Venous thromboembolism : natural history, diagnosis, and management. CRC Press eBooks. 29 indexed citations
16.
Hirsh, Jack. (1987). Venous thrombosis and pulmonary embolism : diagnostic methods. Churchill Livingstone eBooks. 2 indexed citations
17.
Hirsh, Jack. (1986). In vivo Effects of Low Molecular Weight Heparins on Experimental Thrombosis and Bleeding. Pathophysiology of Haemostasis and Thrombosis. 16(2). 82–86. 12 indexed citations
18.
Hirsh, Jack, et al.. (1979). Hemostasis & thrombosis : a conceptual approach. Churchill Livingstone eBooks. 4 indexed citations
19.
Neame, Peter B., Jack Hirsh, & Hymie L. Nossel. (1977). Thrombocytopenia in Septicemia: ? The Role of Disseminated Intravascular Coagulation. Thrombosis and Haemostasis. 3 indexed citations
20.
Genton, Edward, Michael Gent, Jack Hirsh, & Laurence A. Harker. (1975). Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease. New England Journal of Medicine. 293(25). 1296–1300. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey I. Weitz Breakdown of academic impact, for papers by Michael Gent Breakdown of academic impact, for papers by Mark Crowther Breakdown of academic impact, for papers by Harry R. Büller Breakdown of academic impact, for papers by John W. Eikelboom Breakdown of academic impact, for papers by Sam Schulman Breakdown of academic impact, for papers by John A. Heit Breakdown of academic impact, for papers by Clive Kearon Breakdown of academic impact, for papers by Samuel Z. Goldhaber Breakdown of academic impact, for papers by Mark N. Levine
Rankless by CCL
2026